Dunn, L., Mohammad, K., Fournier, P. G. J., McKenna, R., Davis, H., Niewolna, M., Peng, X., Chirgwin, J., & Guise, T. (2009). Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS ONE, 4(9), e6896. doi: 10.1371/journal.pone.0006896. (ID: 17664) ^(E)

Fournier, P. G. J., Dunn, L., Clines, G., & Guise, T. (2009). Tumor-Bone Cell Interactions in Bone Metastases. In Dominique Heymann (Eds.), Bone Cancer - Progression and Therapeutic Approaches (1 ed., pp. 11-40). Academic Press. (ID: 18147) ^(E)

Álvarez Delgado, C., Reyes Chilpa, R., Estrada Muñiz, E., Mendoza Rodríguez, C. A., Quintero Ruiz, A., Solano, J., & Cerbón, M. (2009). Coumarin A/AA induces apoptosis-like cell death in HeLa cells mediated by the release of apoptosis-inducing factor. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 23(4), 263-272. doi: 10.1002/jbt.20288. (ID: 17725) ^(E)

Pearson, G. A., Lago Lestón, M. A., & Mota, C. (2009). Frayed at the edges: selective pressure and adaptive response to abiotic stressors are mismatched in low diversity edge populations. JOURNAL OF ECOLOGY, 97(3), 450-462. doi: 10.1111/j.1365-2745.2009.01481.x. (ID: 18438) ^(E)

Pimienta Rosales, G., Chaerkadi, R., & Pandey, A. (2009). SILAC for Global Phosphoproteomic Analysis. In Marjo de Graaw (Eds.), Phosphoproteomics: Methods and Protocols (pp. 107-116). Humana Press. (ID: 18939) ^(E)

Fournier, P. G. J., Daubiné, F., Lundy, M., Rogers, M., Ebetino, F. H., & Clézardin, P. (2008). Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. CANCER RESEARCH, 68(21), 8945-8953. doi: 10.1158/0008-5472.CAN-08-2195. (ID: 17665) ^(E)

Ponce Coria, J., San Cristobal, P., Kahle, K. T., Vazquez, N., Pacheco Alvarez, D., De Los Heros, P., Juárez Camacho, P., Muñoz, E., Michel, G., Bobadilla, N. A., Gimenez, I., Lifton, R. P., Hebert, S. C., & Gamba, G. (2008). Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proceedings of the National Academy of Sciences of the United States of America, 105(24), 8458-8463. doi: 10.1073/pnas.0802966105. (ID: 18221) ^(E)

Lopez Casillas, F., Vilchis Landeros, M., Esparza Lopez, J., Ponce Castañeda, M. V., Velasco Loyden, N. G., Juárez Camacho, P., Montiel, J. L., & Mendoza, V. (2008). Regulation of the Transforming Growth Factor-ß Superfamily by Betaglycan. In Sonia B. Jacowiew (Eds.), Transforming Growth Factor-ß in Cancer Therapy, Volumen I (1 ed., pp. 451-462). Humana Press. (ID: 18217) ^(E)

Pimienta Rosales, G., & Pascual, J. (2007). Canonical and Alternative MAPK Signaling. CELL CYCLE, 6(21), 2628-2632. doi: 10.4161/cc.6.21.4930. (ID: 17723) ^(E)

Kingsley, L., Fournier, P. G. J., Chirgwin, J., & Guise, T. (2007). Molecular Biology of Bone Metastasis. MOLECULAR CANCER THERAPEUTICS, 6(10), 2609-2617. doi: 10.1158/1535-7163.MCT-07-0234. (ID: 17667) ^(E)